Sunil Verma

1.1k total citations
25 papers, 673 citations indexed

About

Sunil Verma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sunil Verma has authored 25 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Sunil Verma's work include Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Cancer Treatment Studies (8 papers). Sunil Verma is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Cancer Treatment Studies (8 papers). Sunil Verma collaborates with scholars based in Canada, United States and Japan. Sunil Verma's co-authors include M. Clemons, RE Coleman, Mark Clemons, Roberto Hegg, Maureen Trudeau, John R. Mackey, Hiroji Iwata, Javier Cortés, Philippe L. Bédard and Binghe Xu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sunil Verma

25 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sunil Verma Canada	13	343	157	155	111	110	25	673
Charles Cho Canada	15	235 0.7×	325 2.1×	218 1.4×	97 0.9×	236 2.1×	30	1.3k
Christy Osgood United States	11	359 1.0×	167 1.1×	129 0.8×	102 0.9×	132 1.2×	19	541
A.-R. Hanauske Germany	12	229 0.7×	215 1.4×	293 1.9×	84 0.8×	143 1.3×	23	687
M. Satya Murthy United States	16	267 0.8×	104 0.7×	131 0.8×	83 0.7×	273 2.5×	36	726
Aiden Flynn United Kingdom	17	178 0.5×	305 1.9×	413 2.7×	127 1.1×	290 2.6×	31	948
D C Talbot United Kingdom	14	383 1.1×	149 0.9×	42 0.3×	277 2.5×	343 3.1×	26	748
J. Mills United Kingdom	11	290 0.8×	100 0.6×	185 1.2×	172 1.5×	253 2.3×	21	671
Ellen N. Spremulli United States	14	258 0.8×	126 0.8×	144 0.9×	172 1.5×	255 2.3×	25	687
Linda Simpson‐Herren United States	15	288 0.8×	123 0.8×	91 0.6×	158 1.4×	324 2.9×	29	794
Jinming Yu China	16	338 1.0×	364 2.3×	205 1.3×	106 1.0×	163 1.5×	48	826

Countries citing papers authored by Sunil Verma

Since Specialization

Citations

This map shows the geographic impact of Sunil Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Verma more than expected).

Fields of papers citing papers by Sunil Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Verma. The network helps show where Sunil Verma may publish in the future.

Co-authorship network of co-authors of Sunil Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Verma. A scholar is included among the top collaborators of Sunil Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Verma. Sunil Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verma, Sunil, et al.. (2025). One scan, multiple insights: A review of AI-Driven biomarker imaging and composite measure detection in lung cancer screening. SHILAP Revista de lepidopterología. 3(1). 100124–100124. 2 indexed citations

Powell, Charles A., Shanu Modi, Hiroji Iwata, et al.. (2021). 92O Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd). Annals of Oncology. 32. S61–S62. 12 indexed citations

Cortés, Javier, S-B. Kim, S-A. Im, et al.. (2021). LBA1 Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (Pts) with HER2+ metastatic breast cancer (mBC): Results of the randomized phase III DESTINY-Breast03 study. Annals of Oncology. 32. S1287–S1288. 73 indexed citations

Schmid, Peter, Javier Cortés, Mark E. Robson, et al.. (2020). A phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (CAPItello290).. Journal of Clinical Oncology. 38(15_suppl). TPS1109–TPS1109. 12 indexed citations

Mackey, John R., Oleg Lipatov, Nicole McCarthy, et al.. (2014). Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer. Journal of Clinical Oncology. 33(2). 141–148. 106 indexed citations

Verma, Sunil, David Miles, Lorenzo Gianni, et al.. (2012). Results from Emilia, A Phase 3 Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine (X) and Lapatinib (L) in Her2-Positive Locally Advanced or Metastatic Breast Cancer (MBC). Annals of Oncology. 23. ixe5–ixe6. 2 indexed citations

Gandhi, Sonal, et al.. (2011). Patient and Physician Perceptions on Continuing Aromatase Inhibitors beyond the 5-Year Mark. The Breast Journal. 17(6). 620–629. 2 indexed citations

Verma, Sunil & Christian Jackisch. (2011). Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age. Expert Review of Anticancer Therapy. 11(2). 277–286. 2 indexed citations

Chlebowski, Rowan T., Jack Cuzick, Dereck D. Amakye, et al.. (2009). Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer. The Breast. 18. S1–S11. 36 indexed citations

10.

Freedman, Orit, Eitan Amir, Wedad Hanna, et al.. (2009). A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 119(1). 155–161. 12 indexed citations

11.

Verma, Sunil. (2009). HIV: A Raft-Targeting Approach for Prevention and Therapy Using Plant-Derived Compounds (Review). Current Drug Targets. 10(1). 51–59. 26 indexed citations

12.

Bachelot, Thomas, Aňa Lluch, Catherine Prady, et al.. (2009). Activity and safety of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: initial results from a phase II study.. Cancer Research. 69(2_Supplement). 4115–4115. 3 indexed citations

13.

Bédard, Philippe L., et al.. (2008). Matters of the Heart: Cardiac Toxicity of Adjuvant Systemic Therapy for Early-Stage Breast Cancer. Current Oncology. 15(11). 16–29. 20 indexed citations

14.

Capoor, Malini R., Rajeev Malhotra, Sunil Verma, et al.. (2008). Disseminated cryptococcosis with necrotizing fasciitis in an apparently immunocompetent host: a case report. Medical Mycology. 46(3). 269–273. 10 indexed citations

15.

Bria, Emilio, Federica Cuppone, Michèle Milella, et al.. (2008). Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues. Expert Opinion on Biological Therapy. 8(12). 1963–1971. 25 indexed citations

16.

Verma, Sunil, Nan Soon Wong, Maureen Trudeau, et al.. (2007). Survival Differences Observed in Metastatic Breast Cancer Patients Treated With Capecitabine When Compared With Vinorelbine After Pretreatment With Anthracycline and Taxane. American Journal of Clinical Oncology. 30(3). 297–302. 17 indexed citations

17.

Verma, Sunil & Mark Clemons. (2007). First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy. The Oncologist. 12(7). 785–797. 23 indexed citations

18.

Clemons, M., RE Coleman, & Sunil Verma. (2004). Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?. Cancer Treatment Reviews. 30(4). 325–332. 118 indexed citations

19.

Fenton, David, Sunil Verma, Peter Venner, Ravinder Sawhney, & John R. Mackey. (2002). The Lack of Long-Term Effect of Cisplatin Based Combination Chemotherapy on Serum Cholesterol for Treatment of Testicular Cancer. The Journal of Urology. 168(5). 1971–1974. 8 indexed citations

20.

Verma, Sunil, Ian Quirt, E. Eisenhauer, et al.. (1993). A phase II study of weekly Edatrexate (10-EDAM) in metastatic melanoma. Annals of Oncology. 4(3). 254–255. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact